Longwood Capital Partners

Acuta Capital Partners as of March 31, 2016

Portfolio Holdings for Acuta Capital Partners

Acuta Capital Partners holds 40 positions in its portfolio as reported in the March 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Amicus Therapeutics (FOLD) 11.8 $21M 2.5M 8.45
Veracyte (VCYT) 8.3 $15M 2.7M 5.40
Immunomedics 7.7 $14M 5.5M 2.50
Lion Biotechnologies 7.1 $13M 2.5M 5.08
Neuroderm Ltd F 6.5 $12M 827k 14.12
Ascendis Pharma A S (ASND) 6.5 $12M 624k 18.55
Rrsat Global Comm Ntwrk 4.4 $7.9M 608k 13.06
Cynapsus Therapeutics 3.9 $7.0M 591k 11.90
IRIDEX Corporation (IRIX) 3.8 $6.7M 658k 10.22
iShares Russell 2000 Index (IWM) 3.1 $5.5M 50k 110.64
Celator Pharmaceuticals 3.1 $5.5M 500k 11.03
Nabriva Therapeutics 2.7 $4.9M 545k 8.96
Everyday Health 2.6 $4.6M 825k 5.60
Strongbridge Bioph shs usd 2.5 $4.5M 1.1M 4.24
CAS Medical Systems 2.1 $3.8M 2.7M 1.42
Universal Display Corporation (OLED) 2.1 $3.8M 70k 54.10
Cempra 2.1 $3.7M 210k 17.52
Edge Therapeutics 2.0 $3.5M 385k 9.15
Akebia Therapeutics (AKBA) 1.9 $3.5M 386k 9.01
Innocoll Hldgs 1.8 $3.2M 378k 8.58
Teligent Inc note 3.750 12/1 1.8 $3.2M 4.0M 0.80
Oxford Immunotec Global 1.7 $3.1M 308k 9.91
Retrophin 1.5 $2.7M 200k 13.66
Mirati Therapeutics 1.2 $2.2M 103k 21.40
Immunomedics Inc note 4.750% 2/1 1.2 $2.1M 3.0M 0.70
Alimera Sciences 0.9 $1.7M 974k 1.75
Rigel Pharmaceuticals (RIGL) 0.9 $1.6M 777k 2.08
Essa Pharma 0.8 $1.5M 467k 3.26
Pacific Biosciences of California (PACB) 0.8 $1.4M 165k 8.50
Exelixis (EXEL) 0.7 $1.3M 321k 4.00
Progenics Pharmaceuticals 0.6 $1.0M 233k 4.36
Endologix Inc note 2.250%12/1 0.3 $581k 796k 0.73
Aegerion Pharmaceuticals 2% Du cvbond 0.3 $510k 1.0M 0.51
Teligent 0.3 $507k 103k 4.90
Cardica 0.2 $431k 121k 3.56
MannKind Corporation 0.1 $242k 150k 1.61
Second Sight Med Prods 0.1 $242k 50k 4.84
Akari Therapeutics 0.1 $236k 18k 12.93
Combimatrix Corporation 0.1 $171k 47k 3.61
Invivo Therapeutics Hldgs 0.1 $140k 20k 7.00